CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-21 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Sale | −9,890 | $16.60 | $164K | 187,573 |
| 2018-02-21 | dEsparbes Eric Interim PEO, SVP and CFO | Sale | −5,378 | $16.52 | $89K | 291,810 |
| 2018-02-21 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Sale | −8,000 | $16.51 | $132K | 235,473 |
| 2018-02-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −16,700 | $16.44 | $275K | 197,463 |
| 2018-02-20 | dEsparbes Eric Interim PEO, SVP and CFO | Shares withheld for taxes | −24,876 | $16.44 | $409K | 297,188 |
| 2018-02-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −15,500 | $16.44 | $255K | 243,473 |
| 2018-02-12 | DiPaolo Mark Director | Grant or award | +10,517 | 10,517 | ||
| 2018-02-12 | Haimovitz Jules Director | Grant or award | +10,517 | 22,717 | ||
| 2018-02-12 | Schlesinger Sarah J. Director | Grant or award | +10,517 | 10,517 | ||
| 2017-12-19 | Kostas Odysseas D Director | Grant or award | +14,513 | 14,513 | ||
| 2017-12-19 | Bickerstaff George Director | Grant or award | +14,513 | 14,513 | ||
| 2017-12-04 | Aguiar Michael W President & Chief Exec Officer | Sale | −12,022 | $13.13 | $158K | 980,907 |
| 2017-11-21 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Sale | −13,000 | $13.29 | $173K | 213,800 |
| 2017-11-21 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Sale | −5,215 | $13.26 | $69K | 258,651 |
| 2017-11-21 | dEsparbes Eric SVP and CFO | Sale | −13,460 | $13.31 | $179K | 321,742 |
| 2017-11-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −14,757 | $13.17 | $194K | 226,800 |
| 2017-11-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −3,358 | $13.17 | $44K | 263,866 |
| 2017-11-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −6,141 | $13.17 | $81K | 337,027 |
| 2017-11-20 | dEsparbes Eric SVP and CFO | Sale | −1,825 | $13.04 | $24K | 335,202 |
| 2017-11-20 | Aguiar Michael W President & Chief Exec Officer | Shares withheld for taxes | −43,038 | $13.17 | $567K | 992,929 |
Page 12 of 15 · 297 trades